Company Nutra Pharma Corp. OTC Bulletin Board
Equities
US67060U2087
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products and Technologies & Homeopathic and Ethical Drugs
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +88.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 16-07-26 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 02-11-06 |
Stewart Lonky
BRD | Director/Board Member | 75 | 04-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 09-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 12,000,000 | 0 | 0 | 100.00 % |
Stock B | 1 | 7,596,852,214 | 7,596,852,214 ( 100.00 %) | 0 |
Company contact information
![address Nutra Pharma Corp.](https://cdn.zonebourse.com/static/address/22270203.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |